{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:30:14Z","timestamp":1790227814073,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC1403ME50"],"award-info":[{"award-number":["RC1403ME50"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12943-016-0492-8","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T07:42:29Z","timestamp":1452843749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Deregulated expression of cryptochrome genes in human colorectal cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Gianluigi","family":"Mazzoccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Cata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Tiberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Valvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Pazienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Merla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartolomeo","family":"Augello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia Tiziana","family":"Storlazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tavano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bisceglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Colantuoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"492_CR1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuron.2012.04.006","volume":"74","author":"U Albrecht","year":"2012","unstructured":"Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron. 2012;74:246\u201360.","journal-title":"Neuron"},{"key":"492_CR2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg1633","volume":"6","author":"D Bell-Pedersen","year":"2005","unstructured":"Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, Thomas TL, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet. 2005;6:544\u201356.","journal-title":"Nat Rev Genet"},{"key":"492_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","volume":"72","author":"C Dibner","year":"2010","unstructured":"Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517\u201349.","journal-title":"Annu Rev Physiol"},{"key":"492_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-387690-4.00006-4","volume":"74","author":"PL Lowrey","year":"2011","unstructured":"Lowrey PL, Takahashi JS. Genetics of circadian rhythms in Mammalian model organisms. Adv Genet. 2011;74:175\u2013230.","journal-title":"Adv Genet"},{"issue":"29","key":"492_CR5","doi-asserted-by":"crossref","first-page":"25891","DOI":"10.1074\/jbc.M111.254680","volume":"286","author":"R Ye","year":"2011","unstructured":"Ye R, Selby CP, Ozturk N, Annayev Y, Sancar A. Biochemical analysis of the canonical model for the mammalian circadian clock. J Biol Chem. 2011;286(29):25891\u2013902. Jul 22.","journal-title":"J Biol Chem"},{"key":"492_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/07420520802675177","volume":"26","author":"PV Agostino","year":"2009","unstructured":"Agostino PV, Harrington ME, Ralph MR, Golombek DA. Casein kinase-1-epsilon (CK1epsilon) and circadian photic responses in hamsters. Chronobiol Int. 2009;26:126\u201333.","journal-title":"Chronobiol Int"},{"key":"492_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"CK Glass","year":"2012","unstructured":"Glass CK, Liddle C, Auwerx J, Downes M, Panda S, Evans RM. Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature. 2012;485:123\u20137.","journal-title":"Nature"},{"key":"492_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"H Cho","year":"2012","unstructured":"Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, et al. Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature. 2012;485:123\u20137.","journal-title":"Nature"},{"key":"492_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/07420528.2012.658127","volume":"29","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Pazienza V, Vinciguerra M. Clock genes and clock controlled genes in the regulation of metabolic rhythms. Chronobiol Int. 2012;29:227\u201351.","journal-title":"Chronobiol Int"},{"key":"492_CR10","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.4161\/cc.10.21.17974","volume":"10","author":"E Destici","year":"2011","unstructured":"Destici E, Oklejewicz M, Saito S, van der Horst GT. Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner. Cell Cycle. 2011;10:3788\u201397.","journal-title":"Cell Cycle"},{"key":"492_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopha.2011.11.007","volume":"66","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Piepoli A, Carella M, Panza A, Pazienza V, Benegiamo G, et al. Altered expression of the clock gene machinery in kidney cancer. Biomed Pharmacother. 2012;66:175\u20139.","journal-title":"Biomed Pharmacother"},{"key":"492_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/07357907.2011.640650","volume":"30","author":"V Pazienza","year":"2012","unstructured":"Pazienza V, Piepoli A, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, et al. SIRT1 and the Clock gene machinery in colorectal cancer. Cancer Invest. 2012;30:98\u2013105.","journal-title":"Cancer Invest"},{"key":"492_CR13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00432-011-1126-6","volume":"138","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, et al. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138:501\u201311.","journal-title":"J Cancer Res Clin Oncol"},{"key":"492_CR14","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1073\/pnas.0409897102","volume":"102","author":"VY Gorbacheva","year":"2005","unstructured":"Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK\/BMAL1 transactivation complex. Proc Natl Acad Sci U S A. 2005;102:3407\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"492_CR15","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3892\/mmr.2015.3247","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Qian R, Sun N, Lu C, Chen Z, Hua L. Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo. Mol Med Rep. 2015;11(6):4204\u201310.","journal-title":"Mol Med Rep"},{"key":"492_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CEJ.0b013e328341e309","volume":"20","author":"P Rozen","year":"2011","unstructured":"Rozen P, Liphshitz I, Barchana M. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur J Cancer Prev. 2011;20:46\u201353.","journal-title":"Eur J Cancer Prev"},{"key":"492_CR17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","volume":"105","author":"PD Sasieni","year":"2011","unstructured":"Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. What is the lifetime risk of developing cancer: the effect of adjusting for multiple primaries. Br J Cancer. 2011;105:460\u20135.","journal-title":"Br J Cancer"},{"key":"492_CR18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","volume":"47","author":"F Levi","year":"2007","unstructured":"Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593\u2013628.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"492_CR19","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2006.06.1440","volume":"24","author":"S Giacchetti","year":"2006","unstructured":"Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, et al. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European organisation for research and treatment of cancer chronotherapy group. J Clin Oncol. 2006;24:3562\u20139.","journal-title":"J Clin Oncol"},{"key":"492_CR20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/07420528.2011.597532","volume":"28","author":"PF Innominato","year":"2011","unstructured":"Innominato PF, Giacchetti S, Moreau T, Smaaland R, Focan C, Bjarnason GA, et al. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiol Int. 2011;28:586\u2013600.","journal-title":"Chronobiol Int"},{"key":"492_CR21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.bcp.2008.01.011","volume":"75","author":"H Terazono","year":"2008","unstructured":"Terazono H, Hamdan A, Matsunaga N, Hayasaka N, Kaji H, Egawa T, et al. Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes: A possible mechanism of chemotherapy-induced circadian rhythm disturbances. Biochem Pharmacol. 2008;75:1616\u201322.","journal-title":"Biochem Pharmacol"},{"key":"492_CR22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/07420528.2011.569043","volume":"28","author":"C Ahowesso","year":"2011","unstructured":"Ahowesso C, Li XM, Zampera S, Peteri-Brunb\u00e4ck B, Dulong S, Beau J, et al. Sex and dosing-time dependencies in irinotecan-induced circadian disruption. Chronobiol Int. 2011;28:458\u201370.","journal-title":"Chronobiol Int"},{"key":"492_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","volume":"76","author":"DJ Waxman","year":"2009","unstructured":"Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol. 2009;76:215\u201328.","journal-title":"Mol Pharmacol"},{"key":"492_CR24","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1074\/jbc.M808360200","volume":"284","author":"IM Bur","year":"2009","unstructured":"Bur IM, Cohen-Solal AM, Carmignac D, Abecassis PY, Chauvet N, Martin AO, et al. The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism. J Biol Chem. 2009;284:9066\u201373.","journal-title":"J Biol Chem"},{"key":"492_CR25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/07420528.2011.615182","volume":"28","author":"G Mazzoccoli","year":"2011","unstructured":"Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, et al. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int. 2011;28:841\u201351.","journal-title":"Chronobiol Int"},{"key":"492_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0092-8674(00)81199-X","volume":"93","author":"A Balsalobre","year":"1998","unstructured":"Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 1998;93:929\u201337.","journal-title":"Cell"},{"key":"492_CR27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.MP.0000092954.42656.94","volume":"16","author":"A Dahl\u00e9n","year":"2003","unstructured":"Dahl\u00e9n A, Mertens F, Rydholm A, Brosj\u00f6 O, Wejde J, Mandahl N. PanagopoulosI: Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol. 2003;16:1132\u201340.","journal-title":"Mod Pathol"},{"key":"492_CR28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/gcc.20700","volume":"48","author":"D Trombetta","year":"2009","unstructured":"Trombetta D, Mertens F, Lonoce A, D'Addabbo P, Rennstam K, Mandahl N, et al. Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors. Genes Chromosomes Cancer. 2009;48:993\u20131001.","journal-title":"Genes Chromosomes Cancer"},{"key":"492_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00412-004-0296-2","volume":"113","author":"F Gachon","year":"2004","unstructured":"Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma. 2004;113:103\u201312.","journal-title":"Chromosoma"},{"key":"492_CR30","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1093\/annonc\/mds148","volume":"23","author":"S Giacchetti","year":"2012","unstructured":"Giacchetti S, Dugu\u00e9 PA, Innominato PF, Bjarnason GA, Focan C, Garufi C, et al. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann Oncol. 2012;23:3110\u20136.","journal-title":"Ann Oncol"},{"key":"492_CR31","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1158\/0008-5472.CAN-07-0133","volume":"67","author":"W Krugluger","year":"2007","unstructured":"Krugluger W, Brandstaetter A, Ka\u00b4llay E, Schueller J, Krexner E, Kriwanek S, et al. Regulation of genes of the circadian clock in human colon cancer: reduced Period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 2007;67:7917\u201322.","journal-title":"Cancer Res"},{"issue":"4","key":"492_CR32","doi-asserted-by":"crossref","first-page":"e61679","DOI":"10.1371\/journal.pone.0061679","volume":"8","author":"H Yu","year":"2013","unstructured":"Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, et al. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One. 2013;8(4):e61679.","journal-title":"PLoS One"},{"key":"492_CR33","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2007.07.009","volume":"133","author":"WA Hoogerwerf","year":"2007","unstructured":"Hoogerwerf WA, Hellmich HL, Corn\u00e9lissen G, Halberg F, Shahinian VB, Bostwick J, et al. Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen. Gastroenterology. 2007;133:1250\u201360.","journal-title":"Gastroenterology"},{"key":"492_CR34","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1053\/j.gastro.2008.08.048","volume":"135","author":"WA Hoogerwerf","year":"2008","unstructured":"Hoogerwerf WA, Sinha M, Conesa A, Luxon BA, Shahinian VB, Corn\u00e9lissen G, et al. Transcriptional profiling of mRNA expression in the mouse distal colon. Gastroenterology. 2008;135:2019\u201329.","journal-title":"Gastroenterology"},{"key":"492_CR35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2007.05.053","volume":"133","author":"M Sl\u00e1dek","year":"2007","unstructured":"Sl\u00e1dek M, Rybov\u00e1 M, Jindr\u00e1kov\u00e1 Z, Zemanov\u00e1 Z, Polidarov\u00e1 L, Mrnka L, et al. Insight into the circadian clock within rat colonic epithelial cells. Gastroenterology. 2007;133:1240\u20139.","journal-title":"Gastroenterology"},{"key":"492_CR36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2407-10-110","volume":"10","author":"AE Hoffman","year":"2010","unstructured":"Hoffman AE, Zheng T, Ba Y, Stevens RG, Yi CH, Leaderer D, et al. Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways. BMC Cancer. 2010;10:110. Mar 24.","journal-title":"BMC Cancer"},{"issue":"7","key":"492_CR37","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1093\/nar\/gku094","volume":"42","author":"TH Kang","year":"2014","unstructured":"Kang TH, Leem SH. Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome 1. Nucleic Acids Res. 2014;42(7):4427\u201334.","journal-title":"Nucleic Acids Res"},{"key":"492_CR38","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1073\/pnas.0600168103","volume":"103","author":"Y Liu","year":"2006","unstructured":"Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci U S A. 2006;103:4976\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"492_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jmb.2005.06.033","volume":"352","author":"PJ Rochette","year":"2005","unstructured":"Rochette PJ, Bastien N, Lavoie J, Gu\u00e9rin SL, Drouin R. SW480, a p53 double-mutant cell line retains proficiency for some p53 functions. J Mol Biol. 2005;352:44\u201357.","journal-title":"J Mol Biol"},{"key":"492_CR40","doi-asserted-by":"crossref","unstructured":"Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou YY, Kemp MG, Hu J, Lee JH, Ozturk N.Circadian clock, cancer, and chemotherapy. Biochemistry. 2015;54(2):110-123.","DOI":"10.1021\/bi5007354"},{"key":"492_CR41","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.0813028106","volume":"106","author":"N Ozturk","year":"2009","unstructured":"Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci U S A. 2009;106:2841\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"492_CR42","doi-asserted-by":"crossref","first-page":"10668","DOI":"10.1073\/pnas.1106284108","volume":"108","author":"JH Lee","year":"2011","unstructured":"Lee JH, Sancar A. Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis. Proc Natl Acad Sci U S A. 2011;108:10668\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"492_CR43","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1073\/pnas.1108125108","volume":"108","author":"JH Lee","year":"2011","unstructured":"Lee JH, Sancar A. Regulation of apoptosis by the circadian clock through NF-kappaB signaling. Proc Natl Acad Sci U S A. 2011;108:12036\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"492_CR44","doi-asserted-by":"crossref","first-page":"e4798","DOI":"10.1371\/journal.pone.0004798","volume":"4","author":"J Mullenders","year":"2009","unstructured":"Mullenders J, Fabius AW, Madiredjo M, Bernards R, Beijersbergen RL. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One. 2009;4(3):e4798.","journal-title":"PLoS One"},{"issue":"5","key":"492_CR45","doi-asserted-by":"crossref","first-page":"e1002516","DOI":"10.1371\/journal.pcbi.1002516","volume":"8","author":"C G\u00e9rard","year":"2012","unstructured":"G\u00e9rard C, Goldbeter A. Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms. PLoS Comput Biol. 2012;8(5):e1002516.","journal-title":"PLoS Comput Biol"},{"key":"492_CR46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.1086271","volume":"302","author":"T Matsuo","year":"2003","unstructured":"Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255\u20139.","journal-title":"Science"},{"issue":"15","key":"492_CR47","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1158\/0008-5472.CAN-05-1119","volume":"65","author":"MA Gauger","year":"2005","unstructured":"Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 2005;65(15):6828\u201334. Aug 1.","journal-title":"Cancer Res"},{"issue":"6","key":"492_CR48","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1158\/1535-7163.MCT-15-0030","volume":"14","author":"L Fang","year":"2015","unstructured":"Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD, Wang L, et al. Circadian clock gene CRY2 degradation is involved in chemoresistance of colorectal cancer. Mol Cancer Ther. 2015;14(6):1476\u201387.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"492_CR49","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/1078-0432.CCR-13-0171","volume":"20","author":"ZL Zeng","year":"2014","unstructured":"Zeng ZL, Luo HY, Yang J, Wu WJ, Chen DL, Huang P, et al. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2014;20(4):1042\u201352. Feb 15.","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-016-0492-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:37:09Z","timestamp":1567521429000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-016-0492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1186\/s12943-016-0492-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]},"article-number":"6"}}